How Magnetic Composites are Effective Anticancer Therapeutics? A Comprehensive Review of the Literature
Mostafa Yusefi,Kamyar Shameli,Hossein Jahangirian,Sin-Yeang Teow,Leili Afsah-Hejri,Siti Nur Amalina Mohamad Sukri,Kamil Kuča
DOI: https://doi.org/10.2147/IJN.S375964
IF: 7.033
2023-07-02
International Journal of Nanomedicine
Abstract:Mostafa Yusefi, 1, 2 Kamyar Shameli, 3 Hossein Jahangirian, 4 Sin-Yeang Teow, 5 Leili Afsah-Hejri, 6 Siti Nur Amalina Mohamad Sukri, 1 Kamil Kuča 1, 7, 8 1 Malaysia-Japan International Institute of Technology, Universiti Teknologi Malaysia, Kuala Lumpur, Malaysia; 2 Institute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur, 50603, Malaysia; 3 Institute of Virology, School of Medicine, Technical University of Munich, Munich, 81675, Germany; 4 CaroGen Corporation, Farmington, CT, USA; 5 Department of Biology, College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou, Zhejiang Province, 325060, People's Republic of China; 6 Department of Food Safety and Quality, School of Business, Science and Technology, Lakeland University Plymouth, WI 53073, USA; 7 Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic; 8 Biomedical Research Center, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic Correspondence: Kamyar Shameli; Hossein Jahangirian, Tel +4917646555701 ; +16178608429, Email ; Chemotherapy is the most prominent route in cancer therapy for prolonging the lifespan of cancer patients. However, its non-target specificity and the resulting off-target cytotoxicities have been reported. Recent in vitro and in vivo studies using magnetic nanocomposites (MNCs) for magnetothermal chemotherapy may potentially improve the therapeutic outcome by increasing the target selectivity. In this review, magnetic hyperthermia therapy and magnetic targeting using drug-loaded MNCs are revisited, focusing on magnetism, the fabrication and structures of magnetic nanoparticles, surface modifications, biocompatible coating, shape, size, and other important physicochemical properties of MNCs, along with the parameters of the hyperthermia therapy and external magnetic field. Due to the limited drug-loading capacity and low biocompatibility, the use of magnetic nanoparticles (MNPs) as drug delivery system has lost traction. In contrast, MNCs show higher biocompatibility, multifunctional physicochemical properties, high drug encapsulation, and multi-stages of controlled release for localized synergistic chemo-thermotherapy. Further, combining various forms of magnetic cores and pH-sensitive coating agents can generate a more robust pH, magneto, and thermo-responsive drug delivery system. Thus, MNCs are ideal candidate as smart and remotely guided drug delivery system due to a) their magneto effects and guide-ability by the external magnetic fields, b) on-demand drug release performance, and c) thermo-chemosensitization under an applied alternating magnetic field where the tumor is selectively incinerated without harming surrounding non-tumor tissues. Given the important effects of synthesis methods, surface modifications, and coating of MNCs on their anticancer properties, we reviewed the most recent studies on magnetic hyperthermia, targeted drug delivery systems in cancer therapy, and magnetothermal chemotherapy to provide insights on the current development of MNC-based anticancer nanocarrier. Keywords: magnetic nanoparticles, polymer-based magnetic nanocomposites, hyperthermia, external magnetic field, targeted cancer treatments Insights into advanced materials have eminently illuminated several authentic features for medical applications in the past few years to promote a healthy society. Specifically, fascinating and enlightening studies on novel therapies and magnetic nanocomposites (MNCs) are prone to offer solutions for many global health issues including cancer. In a practical example, the treatment of glioblastoma cancer by magnetic hyperthermia therapy (MHT) using magnetic nanoparticles (MNPs) has been approved in Europe. 1 Although MNPs alone have shown some merits in MHT and targeted anticancer drug delivery systems, they have several downsides such as colloidal instability, fast oxidation or sensitivity to air and humidity, self-agglomeration due to dipole–dipole attractions between the bare nanoparticles (NPs), low biocompatibility, undesired biodegradability, low drug encapsulation efficiency, and rapid drug release performance. 2,3 For these reasons, MNPs alone are relatively basic and essential, but not appropriate materials for enhanced pharmaceutical effects in drug delivery systems. To overcome these issues, MNCs with multifunctional counterparts and properties have been widely used in MHT and drug delivery to obtain localized synergistic chemothermotherapy. 4,5 The non-targeted actions of high-dose chemodrugs (such as doxorubicin (DOX) and 5-fluorouracil (5FU)) can cause unwanted side effec -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology